As one of pharmaconutrients,it has been proved that ?-3 polyunsaturated fatty acids can regulate inflammation and immunological function because not only its metabolites are different from other lipids but also it can affect intracellular signal transduction.So the structure、composition and molecular mechanisms of ?-3 polyunsaturated fatty acids are reviewed in this article.

As one of lipid nutrients,it has been proved that ?-3 polyunsaturaed fatty acids can effectively be used in the patients with sepsis,cancer,transplantation,chronic inflammatory diseases and so on,which is related with the molecular mechanisms of regulating the structure and function,cytokines and so on.So the clinical study of ?-3 polyunsaturaed fatty acids on different diseases is reviewed in this article.

Laterally spreading tumor is a new type of colorectal tumor found recently.For its particular shape and develptment of tumor,LST is divided as an independent tumor.LST is associated with colorectal cancer and more research is done on it .The progress of its epidemiology, oncomolecularbiology, diagnosis and therapy is reviewed.

Septic shock induced by gram negative bacteria is the leading cause of inpatient mortality. Now there are two ways in endotoxin induced cellular response: the indirect way of cytokines and the direct way. The article reviewed mechanisms of the direct intracellular way induced by endotoxin.Paid special attentions to the development of transmembrane, intracellular and intranuclear signalling and looked ahead the application in clinic.

Aim To investigate roles of ROS in oxaliplatin-induced PUMA expression and apoptosis in colon cancer cells.Methods ROS was used as an oxidative stress in vitro and PUMA expression was determined by Western blot analysis,the apoptosis induced by ROS was assessed by Hoechst 33258 dye staining,the proliferation of the colon cancer cells treated with oxaliplatin and antioxidant was determined by MTT assay.Results ROS induced apoptosis and PUMA expression in colon cancer cells;suppression of PUMA expression by stable transfecting PUMA anti-sense vector decreased apoptosis induced by ROS;oxaliplatin-induced PUMA expression was abrogated by antioxidant and the proliferation of colon cancer cells treated with oxalipla-tin was increased by antioxidant.Conclusions Our data suggests that PUMA and ROS play important roles in oxaliplatin-induced apoptosis.Oxaliplatin induces PUMA expression and apoptosis partly through ROS in colon cancer cells.

Objective To study the effects of intra-bone marrow injection of donor bone marrow cells in combination with low dose radiation on the immunologic reaction of composite tissue allotransplantation.Methods The inbred SD rats were chosen as donors and inbred Wistar rats as recipients. Overall 40 recipients were classified into 4 groups randomly after allogeneic leg transplantation: group A received transplantation only; group B irradiation in the sublethal level (4.5 Gy?2 at a 4-h interval) and fludarabine (50 mg/kg, i.p.); group C, bone marrow cells were directly injected into the intra-bone marrow cavity of the recipients; group D, using a combination of the injection of fludarabine (50 mg/kg, i.p.), irradiation (4.5 Gy?2, at a 4-h interval) and injection of donor bone marrow cells. The rejection of grafts was observed. 120 days after induction of tolerance the mixed lymphocyte reaction (MIR) and skin grafting were examined to confirm tolerance status. To determine graft-versus-host disease (GVHD), rats in tolerance status were also histologically examined. Results As compared with other groups, mean rejection time and mean survival time of limb allografts were prolonged obviously in group D. Donor-specific tolerance was confirmed in all limb allograft recipients in group D by skin grafting and by MLR, and no signs of GVHD were also histologically examined. Conclusion Using a combination of injection of fludarabine, irradiation in the sublethal level and donor bone marrow cells, we have induced donor-specific immunological tolerance in allogeneic limb transplantation in rats without using any immnosuppressants after the operation.

Objective To clone and analyze rat albumin gene. Methods Total RNA was prepared from rat hepatocytes. cDNA fragment encoding rat albumin was amplified by RT-PCR, and then was cloned into pGEM-T vector. Inserted rat gene was sequenced by ABI PRISM 377DNA Sequencer. Meanwhile, the albumin mRNA expression was observed in hepatocytes treated with 1ng/ml and 1g/ml LPS. Results Rat albumin gene was successfully cloned. The expression of albumin mRNA was inhibited by LPS, and the inhibition was dose dependent. Conclusion The cloned rat albumin gene was composed of 401 base pairs and had 100% nucleotide homology with that reported in Genbank. The albumin expression was decreased in hepatocytes treated with LPS. A stable method of semi-quantitative analysis of rat albumin mRNA was established.

Hepatocellular carcinoma (HCC)is one of the most fatal malignant tumors worldwide.As an important part of cutting-edge re-search fields,proteomics has been widely used in the studies of related diseases and has currently become a crucial experimental approach to research on HCC.Significantly expressed proteins can be identified as potential biomarkers for early diagnosis and targets for therapeutic drugs for HCC.Moreover,they can be used for prediction of the recurrence and prognosis of HCC,as well as for investigation of pathogene-sis of the disease.The proteomic results from worldwide clinical studies of HCC are summarized,and it is suggested that the clinical applica-tion of results of basic research on HCC proteomics will bring great benefit to the diagnosis and treatment of HCC.

As a novel research tool,metabolomics technology can reveal the differences in metabolic profiles during the development and progression of hepatocellular carcinoma (HCC),so it has been widely applied for research on HCC biomarkers.The significance of metabo-lomics in the diagnosis of HCC is briefly described,and the metabolomics research aiming at the discovery of HCC biomarkers,including an-imal experiments and clinical studies of metabolites in the serum,urine,and liver tissue,is reviewed.It is pointed out that analyzing and monitoring metabolites in the development and progression of HCC is of great significance for individualized treatment.